Outcomes of a Peri- and Postoperative Management Protocol for Non-TB Mycobacteria in Lung Transplant Recipients

Affiliations

¹ Department of Medicine, University of Toronto, Toronto, ON, Canada; Multi-Organ Transplant Program, Divisions of Respirology, Toronto General Hospital, Toronto, ON, Canada; Nontuberculous Mycobacteria Program, Division of Respirology, Toronto Western Hospital, Toronto, ON, Canada; West Park Healthcare Centre, Toronto, ON, Canada; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan. Electronic address: thirama@icloud.com.
² Department of Medicine, University of Toronto, Toronto, ON, Canada; Multi-Organ Transplant Program, Divisions of Respirology, Toronto General Hospital, Toronto, ON, Canada.
³ Department of Medicine, University of Toronto, Toronto, ON, Canada; Nontuberculous Mycobacteria Program, Division of Respirology, Toronto Western Hospital, Toronto, ON, Canada; West Park Healthcare Centre, Toronto, ON, Canada.
⁴ Department of Medicine, University of Toronto, Toronto, ON, Canada; Nontuberculous Mycobacteria Program, Division of Respirology, Toronto Western Hospital, Toronto, ON, Canada.
⁵ Department of Medicine, University of Toronto, Toronto, ON, Canada; Infectious Diseases, Toronto General Hospital, Toronto, ON, Canada.

Takashi Hirama et al. Chest. 2020 Aug.

. 2020 Aug;158(2):523-528.

doi: 10.1016/j.chest.2020.01.056. Epub 2020 Apr 2.

¹ Department of Medicine, University of Toronto, Toronto, ON, Canada; Multi-Organ Transplant Program, Divisions of Respirology, Toronto General Hospital, Toronto, ON, Canada; Nontuberculous Mycobacteria Program, Division of Respirology, Toronto Western Hospital, Toronto, ON, Canada; West Park Healthcare Centre, Toronto, ON, Canada; Department of Thoracic Surgery, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Miyagi, Japan. Electronic address: thirama@icloud.com.
² Department of Medicine, University of Toronto, Toronto, ON, Canada; Multi-Organ Transplant Program, Divisions of Respirology, Toronto General Hospital, Toronto, ON, Canada.
³ Department of Medicine, University of Toronto, Toronto, ON, Canada; Nontuberculous Mycobacteria Program, Division of Respirology, Toronto Western Hospital, Toronto, ON, Canada; West Park Healthcare Centre, Toronto, ON, Canada.
⁴ Department of Medicine, University of Toronto, Toronto, ON, Canada; Nontuberculous Mycobacteria Program, Division of Respirology, Toronto Western Hospital, Toronto, ON, Canada.
⁵ Department of Medicine, University of Toronto, Toronto, ON, Canada; Infectious Diseases, Toronto General Hospital, Toronto, ON, Canada.

No abstract available

Cited by

Nontuberculous mycobacterial disease in children: A systematic review and meta-analysis.
Jiang X, Xue Y, Men P, Zhao L, Jia J, Yu X, Huang H. Jiang X, et al. Heliyon. 2024 May 22;10(11):e31757. doi: 10.1016/j.heliyon.2024.e31757. eCollection 2024 Jun 15. Heliyon. 2024. PMID: 38845977 Free PMC article.
Non-tuberculous mycobacterial disease: progress and advances in the development of novel candidate and repurposed drugs.
Gu Y, Nie W, Huang H, Yu X. Gu Y, et al. Front Cell Infect Microbiol. 2023 Oct 2;13:1243457. doi: 10.3389/fcimb.2023.1243457. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37850054 Free PMC article. Review.
Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis.
Hirama T, Tomiyama F, Notsuda H, Watanabe T, Watanabe Y, Oishi H, Okada Y. Hirama T, et al. BMC Pulm Med. 2021 Aug 13;21(1):261. doi: 10.1186/s12890-021-01634-z. BMC Pulm Med. 2021. PMID: 34384425 Free PMC article.